Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström Macroglobulinemia treated with chemo‐immunotherapy: RESULTS FROM THE FIL_BIOWM STUDY
Hematological Oncology（2022）
摘要
The peer review history for this article is available at https://publons.com/publon/10.1002/hon.3082.
更多查看译文
关键词
minimal residual disease, MYD88, progression-free survival, Waldenstrom Macroglobulinemia
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要